Citations

Showing 10 of 108104 citations.

Association of Clinical Specialty With Symptoms of Burnout and Career Choice Regret Among US Resident Physicians
Burke, Sara E. , Wittlin, Natalie M. , Yeazel, Mark W. , Dovidio, John F. , Cunningham, Brooke A. , White, Richard O. , Satele, Daniel , Shanafelt, Tait D. , Ryn, Michelle van , Dyrbye, Liselotte N. , Phelan, Sean M. , Satele, Daniel V, Shanafelt, Tait D , van Ryn, Michelle , Hardeman, Rachel R. , Herrin, Jeph

Mayo Clinic

JAMA | October 26, 2018 | Volume: 320 | Issue: 11 | Pages: 1114

10.1001/jama.2018.12615 | PMID 30422299 Get It

The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction
Schneppenheim, Reinhard , Hellermann, Natalie, Brehm, Maria A. , Klemm, Ulrike, Obser, Tobias, Huck, Volker , Schneider, Stefan W. , Denis, Cécile V. , Tischer, Alexander , Auton, Matthew , Xu, Emma-Ruoqi , Wilmanns, Matthias , Zotz, Rainer B., Xu, Emma-Ruoqi , Wilmanns, Matthias , Auton, Matthew , Tischer, Alexander , März, Winfried

Mayo Clinic

Blood | October 26, 2018 | Volume: 133 | Issue: 4 | Pages: 356-365

10.1182/blood-2018-04-843425 | PMID 30366922 Get It

Abstract The frequent von Willebrand factor (VWF) variant p.Phe2561Tyr is located within the C4 domain, which also harbors the platelet GPIIb/IIIa-binding RGD sequence. To investigate its potential effect on hemostasis, we genotyped 865 patients with coronary artery disease (CAD), 915 with myocardial infarction (MI), and 417 control patients (Ludwigshafen Risk and Cardiovascular Health Study) and performed functional studies of this variant. A univariate analysis of male and female carriers of the Tyr2561 allele aged 55 years or younger revealed an elevated risk for repeated MI (odds ratio, 2.53; 95% confidence interval [CI], 1.07-5.98). The odds ratio was even higher in females aged 55 years or younger, at a value of 5.93 (95% CI, 1.12-31.24). Cone and plate aggregometry showed that compared with Phe2561, Tyr2561 was associated with increased platelet aggregate size both in probands’ blood and with the recombinant variants. Microfluidic assays revealed that the critical shear rate for inducing aggregate formation was decreased to 50% by Tyr2561 compared with Phe2561. Differences in C-domain circular dichroism spectra resulting from Tyr2561 suggest an increased shear sensitivity of VWF as a result of altered association of the C domains that disrupts the normal dimer interface. In summary, our data emphasize the functional effect of the VWF C4 domain for VWF-mediated platelet aggregation in a shear-dependent manner and provide the first evidence that a functional variant of VWF plays a role in arterial thromboembolism.
Definitions of response and remission for the Robarts Histopathology Index
Pai, Rish K. , Khanna, Reena , D’Haens, Geert , Sandborn, William J. , Jeyarajah, Jenny , Feagan, Brian G. , Casteele, Niels Vande , Jairath, Vipul , Jairath, Vipul , Jairath, Vipul , Vande Casteele, N , Jairath, V , Jairath, V , Jairath, Vipul

Mayo Clinic

Gut | October 26, 2018 | Volume: 68 | Issue: 11 | Pages: 2101-2102

10.1136/gutjnl-2018-317547 | PMID 30366909 Get It

Proposed surgical technique to facilitate targeted reinnervation of the infraspinatus: A cadaveric feasibility study
Wyles, Cody C. , Maldonado, Andrés A. , Wagner, Eric R. , Lachman, Nirusha , Spinner, Robert J. , Lachman, Nirusha , Spinner, Robert J , Wagner, Eric R , Wyles, Cody C , Houdek, Matthew T. , Maldonado, Andres A.

Mayo Clinic

Clinical Anatomy | October 26, 2018 | Volume: 32 | Issue: 1 | Pages: 131-136

10.1002/ca.23310 | PMID 30362668 Get It

Restoration of shoulder lateral rotation remains a significant challenge following brachial plexus injury. Transfer of the accessory nerve to suprascapular nerve (SSN) has been widely performed, although with generally poor outcomes for lateral rotation. A recent report suggested a selective infraspinatus reinnervation technique using a radial nerve branch for SSN transfer. This cadaveric study was performed in 7 specimens (14 shoulders). We present technical modifications to achieve additional length to the recipient nerve (suprascapular) that would facilitate direct repair. Key elements of the technique are (1) isolation of the SSN immediately distal to its motor branch to supraspinatus near the superior transverse scapular ligament; and (2) delivery of the transected SSN through the spinoglenoid notch and deep to the infraspinatus for emergence in the infraspinatus‐teres minor interval. Nerve overlap of at least 21 mm was observed in all 14 dissected shoulders between the harvested SSN and radial nerve branches. The mean nerve overlap between harvested branches was 26 mm (range 21–32 mm). The mean harvested SSN length was 59 mm (range 46–80 mm). The mean length of the harvested radial nerve branch was 72 mm (range 65–85 mm). No measurements were significantly different between left and right shoulders or between males and females (smallest P value = 0.1249). Nerve diameter of the two harvested branches was judged to be appropriately compatible for surgical coaptation in all 14 dissected shoulders. We present a variation on a described technique to increase recipient suprascapular nerve length. Additional length of the recipient nerve is achieved through utilization of a more proximal dissection of the suprascapular nerve near the level of the superior transverse scapular ligament and delivering the nerve through the teres minor‐infraspinatus interval. These surgical modifications are of clinical interest when selective reinnervation of the infraspinatus muscle is considered. We believe such a targeted approach can potentially increase shoulder lateral rotation function. Clin. Anat. 32:131–136, 2019. © 2018 Wiley Periodicals, Inc.
Simultaneous Inhibition of MEK and Hh Signaling Reduces Pancreatic Cancer Metastasis
Gu, Dongsheng , Lin, Hai , Zhang, Xiaoli , Fan, Qipeng, Chen, Shaoxiong , Shahda, Safi, Xie, Jingwu , Liu, Yunlong , Sun, Jie

Mayo Clinic

Cancers | October 26, 2018 | Volume: 10 | Issue: 11 | Pages: 403

10.3390/cancers10110403 | PMID 30373214 Get It

Pancreatic cancer, mostly pancreatic ductal adenocarcinoma (PDAC), is one of the most lethal cancer types, with an estimated 44,330 death in 2018 in the US alone. While targeted therapies and immune checkpoint inhibitors have significantly improved treatment options for patients with lung cancer and renal cell carcinomas, little progress has been made in pancreatic cancer, with a dismal 5-year survival rate currently at ~8%. Upon diagnosis, the majority of pancreatic cancer cases (~80%) are already metastatic. Thus, identifying ways to reduce pancreatic cancer metastasis is an unmet medical need. Furthermore, pancreatic cancer is notorious resistant to chemotherapy. While Kirsten RAt Sarcoma virus oncogene (K-RAS) mutation is the major driver for pancreatic cancer, specific inhibition of RAS signaling has been very challenging, and combination therapy is thought to be promising. In this study, we report that combination of hedgehog (Hh) and Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) signaling inhibitors reduces pancreatic cancer metastasis in mouse models. In mouse models of pancreatic cancer metastasis using human pancreatic cancer cells, we found that Hh target gene Gli1 is up-regulated during pancreatic cancer metastasis. Specific inhibition of smoothened signaling significantly altered the gene expression profile of the tumor microenvironment but had no significant effects on cancer metastasis. By combining Hh signaling inhibitor BMS833923 with RAS downstream MEK signaling inhibitor AZD6244, we observed reduced number of metastatic nodules in several mouse models for pancreatic cancer metastasis. These two inhibitors also decreased cell proliferation significantly and reduced CD45+ cells (particularly Ly6G+CD11b+ cells). We demonstrated that depleting Ly6G+ CD11b+ cells is sufficient to reduce cancer cell proliferation and the number of metastatic nodules. In vitro, Ly6G+ CD11b+ cells can stimulate cancer cell proliferation, and this effect is sensitive to MEK and Hh inhibition. Our studies may help design novel therapeutic strategies to mitigate pancreatic cancer metastasis.
Radiation and the heart: systematic review of dosimetry and cardiac endpoints
Thorpe, C.S. , Allen, Sorcha , Daniels, T.B., Rule, William G., Vargas, Carlos , Mookadam, Farouk , Niska, Joshua R, Thorpe, Cameron S, Allen, Sorcha M, Daniels, Thomas B, Schild, Steven E. , Thorpe, Cameron S , Niska, Joshua R.

Mayo Clinic

Expert Review of Cardiovascular Therapy | October 26, 2018 | Volume: 16 | Issue: 12 | Pages: 931-950

10.1080/14779072.2018.1538785 | PMID 30360659 Get It

Mitochondrial ATP synthase β‐subunit production rate and ATP synthase specific activity are reduced in skeletal muscle of humans with obesity
Tran, Lee , Langlais, Paul R. , Hoffman, Nyssa, Roust, Lori R., Katsanos, Christos S. , Katsanos, Christos S

Mayo Clinic

Experimental Physiology | October 26, 2018 | Volume: 104 | Issue: 1 | Pages: 126-135

10.1113/ep087278 | PMID 30362197 Get It

New Findings What is the central question of this study? Humans with obesity have lower ATP synthesis in muscle along with lower content of the β‐subunit of the ATP synthase (β‐F1‐ATPase), the catalytic component of the ATP synthase. Does lower synthesis rate of β‐F1‐ATPase in muscle contribute to these responses in humans with obesity? What is the main finding and its importance? Humans with obesity have a lower synthesis rate of β‐F1‐ATPase and ATP synthase specific activity in muscle. These findings indicate that reduced production of subunits forming the ATP synthase in muscle may contribute to impaired generation of ATP in obesity. AbstractThe content of the β‐subunit of the ATP synthase (β‐F1‐ATPase), which forms the catalytic site of the enzyme ATP synthase, is reduced in muscle of obese humans, along with a reduced capacity for ATP synthesis. We studied 18 young (37 ± 8 years) subjects of which nine were lean (BMI = 23 ± 2 kg m−2) and nine were obese (BMI = 34 ± 3 kg m−2) to determine the fractional synthesis rate (FSR) and gene expression of β‐F1‐ATPase, as well as the specific activity of the ATP synthase. FSR of β‐F1‐ATPase was determined using a combination of isotope tracer infusion and muscle biopsies. Gene expression of β‐F1‐ATPase and specific activity of the ATP synthase were determined in the muscle biopsies. When compared to lean, obese subjects had lower muscle β‐F1‐ATPase FSR (0.10 ± 0.05 vs. 0.06 ± 0.03% h−1; P < 0.05) and protein expression (P < 0.05), but not mRNA expression (P > 0.05). Across subjects, abundance of β‐F1‐ATPase correlated with the FSR of β‐F1‐ATPase (P < 0.05). The specific activity of muscle ATP synthase was lower in obese compared to lean subjects (0.035 ± 0.004 vs. 0.042 ± 0.007 arbitrary units; P < 0.05), but this difference was not significant after the activity of the ATP synthase was adjusted to the β‐F1‐ATPase content (P > 0.05). Obesity impairs the synthesis of β‐F1‐ATPase in muscle at the translational level, reducing the content of β‐F1‐ATPase in parallel with reduced capacity for ATP generation via the ATP synthase complex.
Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker
Tepper, Stewart J. , Buse, Dawn C. , Stewart, Walter F. , Bayliss, Martha , Desai, Pooja , Sapra, Sandhya, Anderson, Karla M., McInerney‐Prichard, Erin, Dodick, David W. , Lipton, Richard B.

Mayo Clinic

Headache: The Journal of Head and Face Pain | October 26, 2018 | Volume: 58 | Issue: 9 | Pages: 1358-1372

10.1111/head.13426 | PMID 30362524 Get It

Objective This study aimed to identify the essential content and amount of information to be collected from people with migraine via a patient‐facing smartphone‐based migraine tracker for them to share with clinicians during live discussions to assist in optimizing migraine management. The proposed tracker is intended for use in non‐interventional research to evaluate disease burden in episodic migraine and chronic migraine patients as assessed by demographic and clinical characteristics and health resource utilization in an integrated delivery network setting. The proposed tracker is not intended for commercial purposes. Background Epidemiological studies suggest migraine is underdiagnosed and undertreated. Studies of patient‐clinician interactions suggest that effective medical communication may help address these issues. Methods Four migraine practice leaders, an epidemiologist with extensive migraine experience, and a measurement expert took part in a modified Delphi panel process to identify data elements that could be collected from people with migraine through a smartphone‐based migraine tracker. Importantly, the proposed tracker would not be intended to replace the patient‐clinician encounter but to support the encounter through enabling the patient to document migraine symptoms and experiences in a timely and accurate manner for sharing with a clinician as part of a broader face‐to‐face discussion. The panel reviewed questions derived from the existing migraine diaries in the public domain, those used in clinical trials, and patient‐centric surveys assessing the impact of migraine on physical function and other related concepts. Key considerations included identification of the most clinically useful data elements for a shared communication tool for people with migraine under the care of a clinician. The panel also identified numerous functionality requirements for such a tool and provided recommendations on the most effective way to present results to a clinician. Results The expert panel opined that people with migraine may value the ability to capture a relatively broad range of information for their own migraine‐tracking purposes, while clinicians will likely find greater value in a small set of data relevant to the management of migraine. The panel identified the 3 most essential concepts in categories of data for a clinician, for which they coined the term “The 3 Fs”: F requency of days with headache; F requency of acute medication usage; and F unctional impairment. Information on the frequency of days with headache was felt to combine with the information on the frequency of acute medication usage to provide essential insights into current migraine management strategy and its outcomes, and to assist considerations of preventive measures. Functional impairment was treated as an effective surrogate for headache severity and was assessed based on the following: degree of difficulty in performing activities of daily living, impact on absenteeism (taking leave from work or cancelling/avoiding other activities) and presenteeism (performing work or other daily activities, with reduced productivity/capability), and amount of rest required as a result of a migraine attack. The modified Delphi panel process resulted in the selection of 13 questions in 8 categories to elicit sufficient and meaningful data comprising headache occurrence, symptoms, daily/preventive and as‐needed/acute medication usage, triggers, ability to concentrate, and functional impairment. The panel also agreed that the tracker should generate 2 distinct reports: one for people with migraine that would include a wider range of data about symptoms and perceived triggers, and a targeted report for the clinician that would place prime emphasis on the 3 Fs for aggregating the results of each headache occurrence and the trend over time. Conclusions A system that easily captures critical data elements about migraine, with specific feedback displays for patients to share with clinicians during live discussions, may offer some benefit to people with migraine and their clinicians by facilitating more objective communication and optimizing management. The tracker’s output may enable people with migraine to track a wide range of data for their own purposes, allowing them to better understand their condition, while a synthesized view of the selected data may support more informed clinical decision‐making for the clinician and individualized, evidence‐based discussion with the patient. As a result, this shared decision‐making tool may enable patients to more accurately convey essential migraine information during live patient‐clinician discussions to drive improved management and patient outcomes.
Temporal Evaluation of Craniofacial Relationships in Apert Syndrome
Lu, Xiaona , Forte, Antonio J. , Sawh‐Martinez, Rajendra , Wu, Robin T. , Cabrejo, Raysa, Gabrick, Kyle S., Steinbacher, Derek M., Alperovich, Michael , Alonso, Nivaldo , Persing, John A. , Forte, Antonio Jorge

Mayo Clinic

Journal of Craniofacial Surgery | October 25, 2018 | Volume: 30 | Issue: 2 | Pages: 317-325

10.1097/scs.0000000000004836 | PMID 30358751 Get It

Abstract Complicated craniofacial malformations interfacing with multiple intracellular regulatory mechanisms, lead to ambiguous growth patterns in Apert syndrome. This study aims to explore the chronology and pathogenesis of the development of craniofacial anatomic relationships and to verify the positional correlates between skull and facial structures in Apert syndrome. Fifty-four computed tomography scans (Apert, n = 18; control, n = 36) were included and divided into 3 age subgroups. Craniofacial 3-dimensional cephalometries were analyzed by Materialize software. The angle between sella-nasion plane and maxillary plane widens 7.74° (P = 0.003) prior to 6 months of age; thereafter, this widening increases by 10.36° (P < 0.001) in 6 months to 2 years of age, and remains increased by 8.9° (P = 0.046) throughout childhood. The angle between Frankfort horizontal plane and maxillary plane widens 5.17° (P = 0.022) before 6 months. Angles SNA, SNB, and ANB showed decreases, averaging 12.23° (P < 0.001), 5.19° (P = 0.004), and 6.72° (P = 0.001), respectively. The linear measurements showed synchronicity and continuing deformity into adulthood. Between 6 months to 2 years of age, the distance from sella to nasion (S-N), anterior nasal spine (S-ANS), and posterior nasal spine (S-PNS) decreased 8% (P = 0.006), 16% (P < 0.001), and 19% (P = 0.002), respectively, and remained shortened into adulthood. The angulation changes occur earlier in development than linear distance reduction in Apert syndrome patients compared with controls. Angular adjustments were not sufficient to maintain normal cranial base length. Facial deformity of Apert syndrome temporally begins with the midface, and affects orbit and mandible later in life.